In a letter to healthcare providers dated 9 November, the Food and Drug Administration said it cannot guarantee the safety and effectiveness of surgical mesh in breast surgery, despite an uptick of surgical mesh use in breast procedures.
“The FDA is aware of increased use of surgical mesh products in breast surgery,” the agency said. “However, the safety and effectiveness of surgical mesh in breast surgery, including in...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?